40 completed, 15 unknown, 13 terminated, 9 withdrawn. 25 Phase 3, 18 Phase 2, 10 Phase 4, 8 Phase 1, 7 Not applicable.
Follow Uveitis, Posterior: new trials by email Literature Review of Uveitis, Posterior trials Research Report on Uveitis, Posterior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant fluocinolone acetonide intravitreal implant - Noninfectious Posterior Uveitis, Uveitis, Posterior | Not yet recruiting | Nantes University Hospital | 100 | 2026-06-01 | 2026-06-24 | |
| Role of OCT & OCT Angiography in Patients With Posterior at the Uveitis Clinic of Assiut University Hospital. Uveitis, Posterior | Not yet recruiting | Assiut University | 25 | 2025-05-01 | 2025-04-21 | |
| A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis Brepocitinib PO QD, Placebo PO QD - Uveitis, Posterior, Uveitis, Intermediate | Phase 3 | Active not recruiting | Priovant Therapeutics, Inc. | 371 | 2024-09-11 | 2026-01-12 |
| Quantification & Classification of Inflammatory Cells in Uveitis Using OCT Anterior Uveitis (AU), Birdshot Chorioretinitis | Recruiting | Oregon Health and Science University | 125 | 2024-09-01 | 2025-07-17 | |
| Pregnancy and Congenital Toxoplasmosis Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. - Congenital Toxoplasmosis, Retinochoroiditis | Completed | Hospices Civils de Lyon | 76 | 2023-05-10 | 2026-01-22 | |
| A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease Companion blood samples with procedure - Autoimmune Diseases, Ulcerative Colitis | Completed | TScan Therapeutics, Inc. | 238 | 2023-01-03 | 2026-09-15 | |
| The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment Yutiq 0.18 MG Drug Implant, Sham Injection - Uveitis, Uveitis, Posterior | Phase 3 | Completed | Texas Retina Associates | 10 | 2022-10-05 | 2026-10-05 |
| Intravitreal Sirolimus as Therapeutic Approach to Uveitis Intravitreal injection 440mcg, Intravitreal injection of sirolimus 880mcg - Uveitis, Intermediate Uveitis | Phase 2 | Withdrawn | Stanford University | 2022-09-01 | 2023-10-26 | |
| Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis Izokibep, Placebo - Uveitis | Phase 2 | Terminated | ACELYRIN Inc. | 96 | 2022-08-23 | 2025-02-21 |
| Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis Fluocinolone Acetonide Intravitreal Implant 0.18 mg - Uveitis, Posterior | Phase 4 | Unknown | Alimera Sciences | 125 | 2022-06-06 | 2024-08-06 |
| Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study Ixekizumab Prefilled Syringe - Uveitis, Posterior, Uveitis, Anterior | Phase 4 | Unknown | Massachusetts Eye Research and Surgery Institution | 20 | 2022-06-01 | 2023-10-16 |
| Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome | Phase 2 / Phase 3 | Unknown | Benha University | 50 | 2022-04-14 | 2022-04-20 |
| Ocular Changes in Vitiligo Patients on Therapy Optical coherence tomography angiography (OCT-A) - Vitiligo, Chorioretinopathy | Unknown | Benha University | 100 | 2022-03-10 | 2022-04-19 | |
| Ozurdex Monotherapy Trial Ozurdex 0.7mg Ophthalmic Implant, Prednisone - Uveitis, Posterior, Uveitis, Intermediate | Phase 4 | Withdrawn | Ottawa Hospital Research Institute | 2021-11-30 | 2025-03-12 | |
| Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert Sham Injector, FAI Insert - Uveitis, Uveitis, Posterior | Phase 3 | Terminated | EyePoint Pharmaceuticals, Inc. | 12 | 2021-10-13 | 2024-12-19 |
| PIC and Its Role in Progression of Pathological Myopia Punctate Inner Choroidopathy | Unknown | Assiut University | 39 | 2020-10-15 | 2021-06-18 | |
| SD-OCT Guided Treatment of Fungal Chorioretinitis Fluconazole 150 mg - Fungal Retinitis | Unknown | Benha University | 10 | 2020-01-15 | 2021-12-15 | |
| Six-months Versus Nine-months ATT for Ocular TB Anti-Tuberculosis Treatment - Tuberculosis (TB), Uveitis | Phase 4 | Completed | L.V. Prasad Eye Institute | 58 | 2020-01-01 | 2024-09-26 |
| Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease Autoimmune Uveitis, Behçet Disease | Unknown | Fakultas Kedokteran Universitas Indonesia | 10 | 2019-11-01 | 2019-10-17 | |
| Safety &Efficacy of CF101 to Subjects With Uveitis CF101, Placebo - Uveitis, Posterior, Uveitis, Intermediate | Phase 2 | Withdrawn | Can-Fite BioPharma | 2019-01-01 | 2018-02-01 |
Showing 20 of 82. Sign in to see all of them.
Uveitis (45) · Uveitis, Intermediate (41) · Panuveitis (27) · Macular Edema (11) · Uveitis, Anterior (10) · Behcet Syndrome (9) · Chorioretinitis (9) · White Dot Syndromes (6) · Birdshot Chorioretinopathy (5) · Retinal Vasculitis (5) · Multifocal Choroiditis (4) · Choroidal Neovascularization (3) · Retinal Vein Occlusion (3) · Sarcoidosis (3)
Uveal Diseases (82) · Eye Diseases (81) · Panuveitis (55) · Uveitis (37) · Retinal Diseases (26) · Choroid Diseases (24) · Choroiditis (19) · Vascular Diseases (16) · Cardiovascular Diseases (15) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (15) · Retinitis (13) · Skin Diseases (13) · Skin and Connective Tissue Diseases (13) · Genetic Diseases, Inborn (12)
secukinumab (7) · Fluocinolone Acetonide (6) · Triamcinolone Acetonide (5) · Bevacizumab (4) · Adrenocorticotropic Hormone (3) · Calcium Dobesilate (3) · Dexamethasone (3) · salicylhydroxamic acid (3) · Interferon alpha-2 (2) · Intravitreal Injections (2) · Methotrexate (2) · Prednisone (2) · Adalimumab (1) · Adrenal Cortex Hormones (1) · Bulk Drugs (1)
Novartis Pharmaceuticals (6) · Clearside Biomedical, Inc. (5) · National Eye Institute (NEI) (5) · Benha University (4) · Allergan (3) · XOMA (US) LLC (3) · Asociación para Evitar la Ceguera en México (2) · Assistance Publique - Hôpitaux de Paris (2) · Assiut University (2) · Changhua Christian Hospital (2) · EyePoint Pharmaceuticals, Inc. (2) · Johns Hopkins University (2) · Lux Biosciences, Inc. (2) · Novartis (2) · Texas Retina Associates (2)
United States (45) · France (15) · Germany (15) · India (11) · Israel (11) · Spain (11) · United Kingdom (11) · Austria (7) · Canada (7) · Brazil (6) · Greece (6) · Italy (6) · Switzerland (6) · Taiwan (6) · Turkey (Türkiye) (6)
Thomas Ciulla, MD (4) · Quan D Nguyen, MD, MSc (3) · Eddy Anglade, M.D. (2) · Hatice N Sen, M.D. (2) · Ahmed A Abdelshafy, MD (1) · Amal A Yousif, MD (1) · Andrii MD Korol, PhD (1) · Antonio Cutino (1) · C. Michael Samson, MD (1) · C. Stephen Foster, MD, FACS, FACR (1)
PMID 23290985, PMID 36787524, PMID 36399237, PMID 12095806, PMID 15079763, PMID 17353400, PMID 18343349, PMID 18639220, PMID 19268890, PMID 20212194, PMID 20212197, PMID 20926833, PMID 21220619, PMID 21629569, PMID 23411886, PMID 23665863, PMID 23761087, PMID 25638011, PMID 25918559, PMID 27980877, PMID 29370572, PMID 30526535, PMID 31385285, PMID 33042579, PMID 33157077, PMID 34322164, PMID 34741564, PMID 36055922, PMID 37172782, PMID 37204866, PMID 38027419, PMID 39250617, PMID 40010761, PMID 40522203
2009 (6), R21EY036563 (1)